Tech Company Financing Transactions
SRTD biotech Funding Round
SRTD biotech, operating out of Jülich, scored investment from High-Tech Gründerfonds and private investors.
Transaction Overview
Company Name
Announced On
12/2/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
High-Tech Gründerfonds (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Huthmacherstrasse 20
Jülich, 52428
Germany
Jülich, 52428
Germany
Phone
Undisclosed
Website
Email Address
Overview
We are developing the first pro-drug platform on RNA level, targeting oncological, viral and genetic diseases. It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed RNAs (seRNAs) to patients. We have an ambitious pipeline that targets indications of highest medical need. Many devastating diseases cannot be effectively treated. Even if therapies exist, often they don't specifically target the diseased area, leading to a high risk of severe side effects. To overcome this inherent problem, we have developed seRNA as a new RNA-based therapy approach.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernd Hoffmann
Chief Financial Officer
Georg Lautscham
Browse more venture capital transactions:
Prev: 12/2/2024: AdvantageClub.ai venture capital transaction
Next: 12/2/2024: Turion Space venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs